Successful treatment of SAPHO syndrome co-occurred with pelvic lipomatosis with adalimumab: A case report

Int J Rheum Dis. 2024 Oct;27(10):e15363. doi: 10.1111/1756-185X.15363.

Authors

Mengzhu Zhu¹, Gongming Li¹, An-Ping Huo^{2

3

4}

Affiliations

¹ Department of Rheumatology, Linyi Traditional Chinese Medicine Hospital, Linyi, Shandong, China.
² Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
³ School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
⁴ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.

PMID: 39373083
DOI: 10.1111/1756-185X.15363

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acquired Hyperostosis Syndrome* / complications
Acquired Hyperostosis Syndrome* / diagnosis
Acquired Hyperostosis Syndrome* / drug therapy
Adalimumab* / therapeutic use
Antirheumatic Agents / therapeutic use
Female
Humans
Lipomatosis* / complications
Lipomatosis* / drug therapy
Middle Aged
Treatment Outcome
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Adalimumab
Tumor Necrosis Factor-alpha
Antirheumatic Agents